Banner for leaf pages 2

Methylphenidate

Also known as Daytrana

Methylphenidate (Ritalin) is a psychostimulant drug approved for treatment of ADHD or attention-deficit hyperactivity disorder, postural orthostatic tachycardia syndrome and narcolepsy. The original patent was owned by CIBA, now Novartis Corporation. It was first licensed by the FDA in 1955 for treating ADHD, prescribed from 1960, and became heavily prescribed in the 1990s, when the diagnosis of ADHD itself became more widely accepted.

Source: Wikipedia

Estimated Total Cost: $41.56 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed methylphenidate to treat attention deficit hyperactivity disorder (adhd), psychotic disorder, developmental disability, and oppositional disorder.

What drug interactions are known?

Do not take methylphenidate if you are taking any of the following:

Critical Interactions

Significant Interactions

Ajax-loader Loading...